DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Hammes HP, Du X, Edelstein D. et al.
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Nat Med 2003;
9: 294-299 doi:10.1038/nm834
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.